Welcome to our dedicated page for Electromed news (Ticker: ELMD), a resource for investors and traders seeking the latest updates and insights on Electromed stock.
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy products for patients with compromised pulmonary function. Its core product references include the SmartVest Airway Clearance System, which combines a programmable air pulse generator, therapy garment, and connecting hose for airway clearance therapy.
Recurring ELMD news centers on quarterly financial results, revenue trends in homecare, hospital, distributor, and other channels, operating leverage, manufacturing and sales-efficiency updates, share repurchase authorizations, and investor conference participation. Company updates also discuss bronchiectasis-focused market education and the role of SmartVest within Electromed's pulmonary-care business.
Electromed, Inc. achieves record revenue in the third quarter of fiscal year 2024, with a 15% increase to $13.9 million compared to the prior year. Operating income rises by 54%, net income reaches $1.49 million, and cash balance grows to $11.7 million. The company's direct homecare business revenue increases by 12%, showing strong growth and operational efficiency. The gross profit margin remains stable at 75%. Electromed continues to focus on driving adoption of its products, enhancing shareholder value, and sustaining operating leverage for profitability.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.